From June 17 to 20, 2026, VivaTech 2026 — Europe’s largest innovation and technology event — grandly opened at the Paris Expo Porte de Versailles. Marking its tenth anniversary, this year’s event was centered around the core themes of “Co-creating the Future, Technology Governance, and Global Innovation Synergy,” bringing together over 10,000 startups alongside industry experts and investors from health tech, artificial intelligence, and other sectors. As one of the representative enterprises from Hong Kong’s technology community, Eieling Technology showcased its two flagship products, Liverscan® and FattaLab®, at the event, demonstrating the company’s technological strength and innovative achievements in liver health diagnostics and therapeutics to a global audience.
Throughout the exhibition, the Eieling Technology booth attracted significant attention and inquiries from European healthcare institutions, health management centers, investment firms, and channel partners. Many professional visitors experienced the products firsthand on-site and highly commended their portability, intelligent operation, and detection efficiency. From Miami to Paris, Eieling Technology continues to deliver a fresh perspective and experience in liver health management through its smart, portable, precise, and user-friendly product features.
Core Strength Rooted in Deep Technological Accumulation
With the rising global prevalence of obesity and fatty liver disease, there is an increasingly urgent need in both clinical diagnostics and health management for liver testing tools that combine high accuracy, portability, and low barriers to repeat testing. The innovative solutions offered by Liverscan® and FattaLab® precisely address this clinical and market gap.
Liverscan® — Beyond Fibrosis, Complete Liver Intelligence
Liverscan® features the world’s exclusive patented real-time 2D ultrasound-guided transient elastography technology, enabling real-time image-guided measurement of liver stiffness and fat content. Empowering medical centers, clinics, and hospitals with precise quantitative assessment of liver fibrosis and steatosis, the product’s performance has been validated by authoritative international publications, demonstrating exceptional detection efficiency and accuracy.
FattaLab® — The Liver Health Dashboard for the GLP-1 Era
FattaLab®, recipient of the CES 2026 Innovation Award, integrates professional-grade liver fat measurement capabilities into a lightweight, pocket-sized device. Powered by the AIFF (Auto Intra-Focus Fusion) algorithm, it enables non-invasive liver fat content measurement in approximately 30 seconds, providing precise and efficient data support for health management and other scenarios.
Many professional visitors experienced the product on-site, intuitively observing the precise localization of the liver target area and the data acquisition process through real-time 2D ultrasound images. Numerous medical industry experts and channel partners expressed recognition for the product’s uniqueness and innovation, while also indicating clear interest in future collaboration. This not only validates Eieling Technology’s technological approach but also lays a solid foundation for the company’s further expansion into the European market.
The successful conclusion of VivaTech 2026 marks an important step in Eieling Technology’s global expansion strategy. Looking ahead, Eieling Technology will continue to deepen its commitment to the field of liver disease diagnosis and treatment, driving product iteration through technological innovation and bringing more precise, more convenient liver health management solutions to a broader global population. We look forward to joining hands with partners worldwide to explore the future possibilities of health technology.
